Combined grey matter VBV and white matter TBSS analysis in young first episode psychosispatients with and without cannabis consumption

Brain Topography

Volumn 26, Issue 4, 2013, Pages 641-647

  Haller, Sven ^a   Curtis, Logos ^b   Badan, Maryse ^b   Bessero, Séverine ^b   Albom, Mara ^b   Chantraine, Fabrice ^b   Alimenti, Alessandro ^a   Lovblad, Karl Olof ^a   Giannakopoulos, Panteleimon ^b   Merlo, Marco ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cannabis; Psychosis; TBSS; VBM

Indexed keywords

ARIPIPRAZOLE; CANNABIS; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; DELUSIONAL DISORDER; DRUG USE; FEMALE; HUMAN; MALE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; STATISTICAL PARAMETERS; SYMPTOM; TRACT BASED SPATIAL STATISTICS; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

ADULT; BRAIN; CANNABIS; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84885074326     PISSN: 08960267     EISSN: 15736792     Source Type: Journal    
DOI: 10.1007/s10548-013-0288-8     Document Type: Article

References (40)

1. Amminger GP, Harris MG, Conus P, Lambert M, Elkins KS, Yuen HP, McGorry PD (2006) Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand 114:337-345
2. Ashburner J, Friston KJ (2000) Voxel-based morphometry: the methods. Neuroimage 11:805-821
3. Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS (2008) Cannabis use and brain structural alterations in first episode schizophrenia: a region of interest, voxel based morphometric study. Schizophr Res 99:1-6
4. Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, Johnston P, Baker A, Schall U (2011) Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Int J Neuropsychopharmacol 4:1-11
5. Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, de Haan L (2010) Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Res 181:51-56
6. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S, Russo M, Paparelli A, Butt A, Stilo SA, Wiffen B, Powell J, Murray RM (2009) High-potency cannabis and the risk of psychosis. Br J Psychiatry 195:488-491
7. Dufton BD, Siddique CM (1992) Measures in the day hospital. I. The global assessment of functioning scale. Int J Partial Hosp 8:41-49
8. Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C (2009) Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108:104-113
9. Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, Mc Guire P, Sacchetti E (2011) Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 35:1175-1185
10. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64:774-781
11. Habets P, Marcelis M, Gronenschild E, Drukker M, van Os J (2011) Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry 69:487-494
12. Henquet C, Murray R, Linszen D, van Os J (2005) The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31:608-612
13. Hermann D, Schneider M (2012) Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. Curr Pharm Des 18:4897-4905
14. Ho BC, Wassink TH, Ziebell S, Andreasen NC (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128:66-75
15. Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162:2233-2245
16. James A, Hough M, James S, Winmill L, Burge L, Nijhawan S, Matthews PM, Zarei M (2011) Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res 128:91-97
17. Kyriakopoulos M, Frangou S (2009) Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 22:168-176
18. Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T (2012) Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci 263(1):3-13
19. Martin-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P (2010) Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 40:383-398
20. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319-328
21. Navari S, Dazzan P (2009) Do antipsychotic drugs affect brain structure? a systematic and critical review of MRI findings. Psychol Med 39:1763-1777
22. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
23. Peters BD, de Haan L, Vlieger EJ, Majoie CB, den Heeten GJ, Linszen DH (2009) Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? Psychopharmacol Bull 42:75-88
24. Potvin S, Mancini-Marie A, Fahim C, Mensour B, Levesque J, Karama S, Beauregard M, Rompre PP, Stip E (2007) Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Res 154:275-279
25. Quickfall J, Crockford D (2006) Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18:318-332
26. Rais M, Cahn W, Van Haren N, Schnack H, Caspers E, Hulshoff Pol H, Kahn R (2008) Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 165:490-496
27. Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2010) Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur Neuropsychopharmacol 20:855-865
28. Rapp C, Bugra H, Riecher-Rossler A, Borgwardt S (2012) Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post-mortem studies. Curr Pharm Des 18(32):5070-5080
29. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511-2518
30. Schnell T, Kleiman A, Gouzoulis-Mayfrank E, Daumann J, Becker B (2012) Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL. Schizophr Res 138(2-3):183-187
31. Semple DM, McIntosh AM, Lawrie SM (2005) Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 19:187-194
32. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rossler A, Borgwardt SJ (2009) The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? a systematic review. Curr Pharm Des 15:2535-2549
33. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83-98
34. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208-S219
35. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505
36. Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, Robson MD, Jones DK, Klein JC, Bartsch AJ, Behrens TE (2007) Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2:499-503
37. Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, Betensky JD, Lencz T, Ashtari M, Kane JM, Malhotra AK, Gunduz-Bruce H, Napolitano B, Bilder RM (2007) Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry 190:230-236
38. Wechsler D (1981) Adult Intelligence Scale, revised (WAIS-R). Psychological Corporation, San Antonio, TX
39. Wobrock T, Sittinger H, Behrendt B, D'Amelio R, Falkai P (2009) Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci 259:28-36
40. Zimmerman P, Fimm B (1994) Tests d'evaluation de l'attention (TEA) (Version 1.02, française). Psytest, WuÂ̈rselen